Average Co-Inventor Count = 8.97
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (12 from 1,970 patents)
2. Medarex Inc. (3 from 152 patents)
3. Corvus Pharmaceuticals, Inc. (1 from 15 patents)
16 patents:
1. 11306107 - Compounds that inhibit MCL-1 protein
2. 11254686 - Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor
3. 10836779 - Compounds that inhibit MCL-1 protein
4. 10100063 - Compounds that inhibit Mcl-1 protein
5. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
6. 9376425 - Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
7. 9359355 - Fused tricyclic dual inhibitors of CDK 4/6 and FLT3
8. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
9. 8980903 - Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
10. 8841312 - Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors
11. 8623885 - Fused tricyclic dual inhibitors of CDK 4/6 and FLT3
12. 8569341 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
13. 8389533 - Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
14. 7129261 - Cytotoxic agents
15. 7087600 - Peptidyl prodrugs and linkers and stabilizers useful therefor